{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:42:24Z","timestamp":1792791744966,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000032","name":"Government of Canada | CIHR | Institute of Infection and Immunity","doi-asserted-by":"publisher","award":["PJT-153057"],"award-info":[{"award-number":["PJT-153057"]}],"id":[{"id":"10.13039\/501100000032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New Frontiers in Research Fund - Explorations","award":["NRFRE-2018-01386"],"award-info":[{"award-number":["NRFRE-2018-01386"]}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sub-Saharan African Network for TB\/HIV Research Excellence","award":["107752\/Z\/15\/Z"],"award-info":[{"award-number":["107752\/Z\/15\/Z"]}]},{"name":"Queen Elizabeth II Diamond Jubilee Scholarship","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK123733"],"award-info":[{"award-number":["R01 DK123733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Penn Center for AIDS Research","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}],"id":[{"id":"https:\/\/ror.org\/047939x15","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beyond Antiretroviral Treatment (BEAT)-HIV Delaney Collaboratory grant","award":["UM1AI126620"],"award-info":[{"award-number":["UM1AI126620"]}]},{"name":"CLAWS Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100010633","name":"The Philadelphia Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100010633","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Philadelphia Field Initiating Group for HIV-1 Trials","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Merck Inc.","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Ken Nimblett and the Summerhill Trust","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"The Herbert Kean, M.D., Family Professorship","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1074\/jbc.ra120.013031","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T17:45:43Z","timestamp":1597167943000},"page":"14084-14099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The African natural product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal"],"prefix":"10.1016","volume":"295","author":[{"given":"Khumoekae","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Schonhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila B.","family":"Giron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Rivera-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silven","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitha","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie N.","family":"Kinloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniqa","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Feilcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Wappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Imming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabrina L.","family":"Brumme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-1426","authenticated-orcid":false,"given":"Mark A.","family":"Brockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam","family":"Mounzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Kossenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Andrae-Marobela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tietjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA120.013031_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"HIV","volume":"392","author":"Ghosn","year":"2018","journal-title":"Lancet"},{"key":"10.1074\/jbc.RA120.013031_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.013031_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA120.013031_bib4","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1073\/pnas.0736332100","article-title":"Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence","volume":"100","author":"Strain","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA120.013031_bib5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.RA120.013031_bib6","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-019-03156-8","article-title":"Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs","volume":"76","author":"Sadowski","year":"2019","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/jbc.RA120.013031_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.013031_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"Novel ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA120.013031_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.03.008","article-title":"HIV \u201cshock and kill\u201d therapy: in need of revision","volume":"166","author":"Abner","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1074\/jbc.RA120.013031_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/med.21638","article-title":"Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens","volume":"40","author":"Hashemi","year":"2019","journal-title":"Med. Res. Rev"},{"key":"10.1074\/jbc.RA120.013031_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2019.03.004","article-title":"Between a shock and a hard place: challenges and developments in HIV latency reversal","volume":"38","author":"Zerbato","year":"2019","journal-title":"Curr. Opin. Virol"},{"key":"10.1074\/jbc.RA120.013031_bib12","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency\u2013reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA120.013031_bib13","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitroex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA120.013031_bib14","doi-asserted-by":"crossref","first-page":"e1005066","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic reactivation of latent HIV expression by ingenol-3-Angelate, PEP005, targeted NF-\u03baB signaling in combination with JQ1 induced p-TEFb activation","volume":"11","author":"Jiang","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA120.013031_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/v10070348","article-title":"Identification of novel HIV-1 latency-reversing agents from a library of marine natural products","volume":"10","author":"Richard","year":"2018","journal-title":"Viruses"},{"key":"10.1074\/jbc.RA120.013031_bib16","first-page":"3473","article-title":"Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation","volume":"119","author":"Yang","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA120.013031_bib17","doi-asserted-by":"crossref","first-page":"e84964","DOI":"10.1371\/journal.pone.0084964","article-title":"Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110 that reactivates latent HIV-1","volume":"9","author":"Doyon","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA120.013031_bib18","doi-asserted-by":"crossref","first-page":"e90655","DOI":"10.1371\/journal.pone.0090655","article-title":"Virtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plants","volume":"9","author":"Ntie-Kang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA120.013031_bib19","doi-asserted-by":"crossref","first-page":"e0121099","DOI":"10.1371\/journal.pone.0121099","article-title":"Screening of the pan-African Natural Product Library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors","volume":"10","author":"Tietjen","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA120.013031_bib20","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA120.013031_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.15252\/emmm.201708193","article-title":"Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency","volume":"10","author":"Hashemi","year":"2018","journal-title":"EMBO Mol. Med"},{"key":"10.1074\/jbc.RA120.013031_bib22","doi-asserted-by":"crossref","first-page":"e00012","DOI":"10.1128\/JVI.00012-17","article-title":"Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition","volume":"91","author":"Cummins","year":"2017","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA120.013031_bib23","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-\u03baB","volume":"279","author":"Williams","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA120.013031_bib24","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1128\/JVI.76.16.8118-8123.2002","article-title":"Effects of prostratin on T-cell activation and human immunodeficiency virus latency","volume":"76","author":"Korin","year":"2002","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA120.013031_bib25","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/jm00089a006","article-title":"A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1","volume":"35","author":"Gustafson","year":"1992","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA120.013031_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jep.2017.09.038","article-title":"The Croton megalobotrys M\u00fcll Arg. traditional medicine in HIV\/AIDS management: documentation of patient use, in vitro activation of latent HIV-1 provirus, and isolation of active phorbol esters","volume":"211","author":"Tietjen","year":"2018","journal-title":"J. Ethnopharmacol"},{"key":"10.1074\/jbc.RA120.013031_bib27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.fct.2009.03.032","article-title":"Prooxidant action of knipholone anthrone: copper dependent reactive oxygen species generation and DNA damage","volume":"47","author":"Habtemariam","year":"2009","journal-title":"Food Chem. Toxicol"},{"key":"10.1074\/jbc.RA120.013031_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0306-3623(96)00075-4","article-title":"Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects","volume":"27","author":"M\u00fcller","year":"1996","journal-title":"Gen. Pharmacol"},{"key":"10.1074\/jbc.RA120.013031_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000210836","article-title":"Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris","volume":"3","author":"Kem\u00e9ny","year":"1990","journal-title":"Skin Pharmacol"},{"key":"10.1074\/jbc.RA120.013031_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2174\/1389450111314060005","article-title":"Sirtuin-1 and HIV-1: an overview","volume":"14","author":"Pinzone","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1074\/jbc.RA120.013031_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/viro.1997.8798","article-title":"TNF\u03b1 cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements","volume":"237","author":"Rabbi","year":"1997","journal-title":"Virology"},{"key":"10.1074\/jbc.RA120.013031_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1179555717694535","article-title":"cAMP signaling enhances HIV-1 long terminal repeat (LTR)-directed transcription and viral replication in bone marrow progenitor cells","volume":"10","author":"Banerjee","year":"2017","journal-title":"Clin. Med. Insights Pathol"},{"key":"10.1074\/jbc.RA120.013031_bib33","doi-asserted-by":"crossref","first-page":"e1000495","DOI":"10.1371\/journal.ppat.1000495","article-title":"Epigenetic regulation of HIV-1 latency by cytosine methylation","volume":"5","author":"Kauder","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA120.013031_bib34","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1128\/JVI.01107-16","article-title":"Novel acylguanidine-based inhibitor of HIV-1","volume":"90","author":"Mwimanzi","year":"2016","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA120.013031_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/COH.0000000000000279","article-title":"Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?","volume":"11","author":"Rasmussen","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1074\/jbc.RA120.013031_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1055\/s-2006-960859","article-title":"Antiplasmodial activity of knipholone and related natural phenylanthraquinones","volume":"65","author":"Bringmann","year":"1999","journal-title":"Planta Med"},{"key":"10.1074\/jbc.RA120.013031_bib37","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.foodchem.2006.06.040","article-title":"Antioxidant activity of Knipholone anthrone","volume":"102","author":"Habtemariam","year":"2007","journal-title":"Food Chem"},{"key":"10.1074\/jbc.RA120.013031_bib38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/b803784c","article-title":"Knipholone and related 4-phenylanthraquinones: structurally, pharmacologically, and biosynthetically remarkable natural products","volume":"25","author":"Bringmann","year":"2008","journal-title":"Nat. Prod. Rep"},{"key":"10.1074\/jbc.RA120.013031_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4238\/2012.February.17.3","article-title":"Effects of the antipsoriatic drug dithranol on E2A and caspase-9 gene expression in vitro","volume":"11","author":"Ronpirin","year":"2012","journal-title":"Genet. Mol. Res"},{"key":"10.1074\/jbc.RA120.013031_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpba.2019.05.065","article-title":"Biological activity and stability analyses of knipholone anthrone, a phenyl anthraquinone derivative isolated from Kniphofia foliosa Hochst","volume":"174","author":"Feilcke","year":"2019","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1074\/jbc.RA120.013031_bib41","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI85339","article-title":"Dual targeting of the thioredoxin and glutathione systems in cancer and HIV","volume":"126","author":"Benhar","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA120.013031_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-6-52","article-title":"\u201cShock and kill\u201d effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence","volume":"6","author":"Savarino","year":"2009","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.RA120.013031_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1166\/sl.2013.2715","article-title":"Anthrone derivatives as voltammetric sensors for applications in metal ion detection","volume":"11","author":"Mittal","year":"2013","journal-title":"Sensor Lett"},{"key":"10.1074\/jbc.RA120.013031_bib44","first-page":"511","article-title":"Generation and role of superoxide ion in the autoxidation of 1,8-dihydroxy-9-anthrone","volume":"115","author":"D'Ischia","year":"1985","journal-title":"Gazzetta Chimica Italiana"},{"key":"10.1074\/jbc.RA120.013031_bib45","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1128\/jvi.65.9.4645-4653.1991","article-title":"Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection","volume":"65","author":"Butera","year":"1991","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA120.013031_bib46","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0031-9422(00)83479-2","article-title":"Knipholone: a unique anthraquinone derivative from Kniphofia foliosa","volume":"23","author":"Dagne","year":"1984","journal-title":"Phytochemistry"},{"key":"10.1074\/jbc.RA120.013031_bib47","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0031-9422(91)80048-6","article-title":"Knipholone anthrone from Kniphofia foliosa","volume":"34","author":"Dagne","year":"1993","journal-title":"Phytochemistry"},{"key":"10.1074\/jbc.RA120.013031_bib48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41385-020-0279-5","article-title":"Sialylation and fucosylation modulate inflammasome-activating eIF2 signaling and microbial translocation during HIV infection","volume":"13","author":"Giron","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1074\/jbc.RA120.013031_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.RA120.013031_bib50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform"},{"key":"10.1074\/jbc.RA120.013031_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1074\/jbc.RA120.013031_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behavioural Brain Res"},{"key":"10.1074\/jbc.RA120.013031_bib53","doi-asserted-by":"crossref","first-page":"e1005677","DOI":"10.1371\/journal.ppat.1005677","article-title":"Human galectin-9 is a potent mediator of HIV transcription and reactivation","volume":"12","author":"Abdel-Mohsen","year":"2016","journal-title":"PLoS Pathog"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192581749805X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192581749805X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA120.013031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T06:41:41Z","timestamp":1664088101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192581749805X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":53,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S002192581749805X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra120.013031","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The African natural product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA120.013031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Richard et al.","name":"copyright","label":"Copyright"}]}}